Skip to main content
Erschienen in: Journal of Cancer Survivorship 3/2018

02.02.2018 | Review

Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?

verfasst von: Ekim Ekinci, Salima Nathoo, Thushara Korattyil, Aisha Vadhariya, Hanna A. Zaghloul, Polly A. Niravath, Susan M. Abughosh, Meghana V. Trivedi

Erschienen in: Journal of Cancer Survivorship | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Endocrine therapy reduces the risk of breast cancer recurrences and mortality in hormone receptor-positive (HR+) breast cancer survivors. However, non-adherence to treatment remains a significant problem. The aim of this study was to review current literature and ongoing trials to identify interventions employed to improve adherence to adjuvant endocrine therapy (AET) in breast cancer survivors.

Methods

We searched PubMed and the National Library of Medicine registry of clinical trials using the terms “breast cancer” and “adherence” or “compliance” and “intervention” and “medication” or “endocrine therapy” or “hormone therapy” to identify published studies as well as ongoing clinical trials.

Results

Three hundred and sixty-three studies were identified; five studies met the inclusion criteria. Most studies enrolled postmenopausal women diagnosed with early stage HR+ breast cancer. Providing educational materials was the most common intervention implemented to improve adherence to one or more aromatase inhibitors. None of the studies found a significant improvement in adherence with the intervention evaluated. Twelve clinical trials investigating various interventions, mostly based on technology, to improve AET adherence were also identified.

Conclusions

Improving adherence to AET in HR+ breast cancer survivors is an urgent medical need. While newer clinical trials are overcoming some of the limitations seen with published studies, tailored interventions led by clinicians need further investigation.

Implications for cancer survivors

Our study highlights the unmet clinical need to develop and test feasible interventions to improve AET adherence in HR+ breast cancer survivors to extend their long-term survival.
Literatur
13.
Zurück zum Zitat Hadji P, Blettner M, Harbeck N, Jackisch C, Luck HJ, Windemuth-Kieselbach C, et al. The Patient’s anastrozole compliance to therapy (PACT) program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer. Ann Oncol. 2013;24(6):1505–12. https://doi.org/10.1093/annonc/mds653.CrossRefPubMed Hadji P, Blettner M, Harbeck N, Jackisch C, Luck HJ, Windemuth-Kieselbach C, et al. The Patient’s anastrozole compliance to therapy (PACT) program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer. Ann Oncol. 2013;24(6):1505–12. https://​doi.​org/​10.​1093/​annonc/​mds653.CrossRefPubMed
15.
Zurück zum Zitat KD Y, Zhou Y, Liu GY, Li B, He PQ, Zhang HW, et al. A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients’ persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancer. Breast Cancer Res Treat. 2012;134(1):307–13. https://doi.org/10.1007/s10549-012-2059-8.CrossRef KD Y, Zhou Y, Liu GY, Li B, He PQ, Zhang HW, et al. A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients’ persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancer. Breast Cancer Res Treat. 2012;134(1):307–13. https://​doi.​org/​10.​1007/​s10549-012-2059-8.CrossRef
18.
Zurück zum Zitat Neven P, Markopoulos C, Tanner M, Marty M, Kreienberg R, Atkins L, et al. The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: first-year results from the compliance of aromatase inhibitors assessment in daily practice through educational approach (CARIATIDE) study. Breast. 2014;23(4):393–9. https://doi.org/10.1016/j.breast.2014.02.009.CrossRefPubMed Neven P, Markopoulos C, Tanner M, Marty M, Kreienberg R, Atkins L, et al. The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: first-year results from the compliance of aromatase inhibitors assessment in daily practice through educational approach (CARIATIDE) study. Breast. 2014;23(4):393–9. https://​doi.​org/​10.​1016/​j.​breast.​2014.​02.​009.CrossRefPubMed
19.
Zurück zum Zitat Nogaret J-M, Coibion M, Neven P, Soepenberg O, Graas M-P, Deschamp V, (2011) Evaluating the impact of educational material on anastrozole treatment adherence—the final results of the artemis study. Cancer Res 71 (24 Suppl):Abstract nr P3–08-02. https://doi.org/10.1016/S0960-9776(11)70233-8 Nogaret J-M, Coibion M, Neven P, Soepenberg O, Graas M-P, Deschamp V, (2011) Evaluating the impact of educational material on anastrozole treatment adherence—the final results of the artemis study. Cancer Res 71 (24 Suppl):Abstract nr P3–08-02. https://​doi.​org/​10.​1016/​S0960-9776(11)70233-8
23.
27.
Zurück zum Zitat Albert US, Zemlin C, Hadji P, Ziller V, Kuhler B, Frank-Hahn B, et al. The impact of breast care nurses on Patients’ satisfaction, understanding of the disease, and adherence to adjuvant endocrine therapy. Breast Care (Basel). 2011;6(3):221–6. https://doi.org/10.1159/000329006.CrossRef Albert US, Zemlin C, Hadji P, Ziller V, Kuhler B, Frank-Hahn B, et al. The impact of breast care nurses on Patients’ satisfaction, understanding of the disease, and adherence to adjuvant endocrine therapy. Breast Care (Basel). 2011;6(3):221–6. https://​doi.​org/​10.​1159/​000329006.CrossRef
Metadaten
Titel
Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?
verfasst von
Ekim Ekinci
Salima Nathoo
Thushara Korattyil
Aisha Vadhariya
Hanna A. Zaghloul
Polly A. Niravath
Susan M. Abughosh
Meghana V. Trivedi
Publikationsdatum
02.02.2018
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 3/2018
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-017-0674-4

Weitere Artikel der Ausgabe 3/2018

Journal of Cancer Survivorship 3/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.